IFRXInflaRx N.V.vs its industry peers
A metric-by-metric comparison of InflaRx N.V. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IFRX본 종목 | $150M#6 | — | — | — | — | — | — | — | — | — | 76.2%#1 | — |
| HELP | $300M#4 | — | — | — | — | — | — | — | — | — | — | — |
| HMDCF | — | — | — | — | -13.0%#2 | 1111.0%#2 | -7.1%#2 | 36.9%#1 | 0.0%#2 | — | — | — |
| HSTC | — | — | — | — | — | -0.8%#4 | — | -11.8%#2 | — | — | — | — |
| HYFT | $61M#7 | — | — | — | — | — | — | — | — | — | -15.5%#3 | — |
| IMMP | $477M#2 | — | — | — | — | — | — | — | — | — | -80.8%#7 | — |
| IMRN | $281M#5 | — | — | — | — | — | — | — | — | — | -34.8%#5 | — |
| IMRX | — | — | — | — | -100.0%#3 | 8.2%#3 | — | -29.4%#3 | — | — | -44.5%#6 | — |
| INCR | $312M#3 | — | — | — | — | — | — | — | — | — | -26.8%#4 | — |
| INDV | $4.2B#1 | 12.7x#1 | — | 3.4x#1 | 4.3%#1 | 2900.0%#1 | 21.1%#1 | — | 403.9%#1 | 4#1 | 54.2%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice